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Abstract 
 
Patient reported outcomes (PROs) refer to any report of the status of a patient's health 
condition that comes directly from the patient. While PROs are a well-developed technology 
with robust standards in research their use for informing health care decisions is generally 
poorly understood. In this paper we review relevant examples of their application in health 
care provision to date, and examine the challenges associated with routinely implementing 
PROs in clinical settings. We evaluate evidence for their use, and examine key barriers, such 
as where there is a lack of alignment between interpretation of scores and clinical decision 
making on the ground. Based on available evidence we have developed a framework of the 
key requirements for the successful implementation of PROs in clinical practice. We conclude 
by exploring potential future developments for the use of PROs in clinical practice, such as 
individualised measurement and efficient administration through the use of computer 
adaptive tests (CATs). 
 
[Abstract word limit = 120 words, currently 154] 
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Introduction  
 
Patient Reported Outcome (PROs) measures (also sometimes referred to as PROMs) are 
health status assessments elicited directly from patients, usually in the form of standardised 
questionnaires. To date, PROs have been used mainly for research purposes and occasionally 
also for monitoring the health of a given population, mostly as part of population surveys. In 
some countries, notably in the National Health Service (NHS) in England, there has been an 
explicit effort to put them at the centre of the development of a more patient centred, 
outcomes oriented performance model [1]. 
 
Aggregated measurements of PROs for well-defined populations have a potentially huge role 
to play a driver of patient centred quality improvement. A critical step towards that aim, 
however, will be whether success is achieved in their use at the level of individual clinical 
decision making, which currently constitutes an underdeveloped area of implementation. 
There is therefore a pressing need to evaluate the challenges of using PROs in clinical practice, 
scrutinising implementation and the evidence supporting their use.  
 
In this paper we will: 
 Provide an overview of what PROs are, including the different types of measure and 
applications. 
 
 Evaluate the research evidence for the use of PROs in clinical practice. 
 
 Review previous experiences of utilising PROs at both the aggregated and the 
individual level. 
    
 Provide a framework for the successful implementation of PROs in clinical settings. 
 
 Explore potential future developments for the use of PROs in clinical practice. 
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Overview of PROs  
 
Over recent years there has been a great expansion in the use of PROs, especially for research 
purposes, yet there have been some confusion as to what the term “PRO” actually refers to. 
For the purpose of this review we will use the definition provided by the US Food and Drug 
Administration, which defines PRO as an umbrella term that incorporates “any report of the 
status of a patient's health condition that comes directly from the patient, without 
interpretation of the patient's response by a clinician or anyone else” [2]. The appeal of this 
terminology is rooted in the fact that it avoids much of the theoretical debate surrounding 
the conceptualisation and definition of many key related constructs, such as perceived health, 
health status, (health related) quality of life and well-being, while at the same time 
emphasising the genuine importance of the individual’s own perspective when making an 
evaluation on their health [3]. In this paper we refer to PROs in relation to overall constructs 
and PROMs where we refer instruments operationalising the measurement of the construct. 
 
A previous model-based classification system for research and clinical practice has established 
three guiding concepts for PROMs: construct, population and measurement [3]. Firstly, 
construct refers to the range of characteristics (traits and states) measured by the instrument 
along with its measurement object (e.g. symptom status, functional status, health 
perceptions, health related quality of life). Secondly, the population of a PROM is the range 
of people for who the instrument is suitable (e.g. age, gender, condition, and culture). Thirdly, 
measurement incorporates i) metric (the method used to assign numeric values to the 
responses given by the individuals and the construction of the scores), ii) dimensionality (the 
number of scores produced for each individual), iii) adaptability (the extent to which the 
instrument can be tailored to the specific circumstances and preferences of each individual - 
the degree to which measurement is standardised or individualised). 
 
The majority of PROMs tend to be presented in the form of fully standardised questionnaires 
with fixed items and response options. The first widely used PROMs included the Sickness 
Impact Profile [4], the Nottingham Health Profile [5], and the Instrumental Activities of Daily 
Living [6]. Most widely used measures today include the EuroQOL EQ-5D [7] and the Short 
Form SF-36 [8]. These were originally classified as generic measures, e.g. applicable across 
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and within populations, regardless of gender, and disease or condition. However the 
traditional distinction between generic and specific instruments has been challenged based 
on the fact that many so called generic measures do not actually cover all major constructs 
(symptoms, function, health perceptions, health related quality of life), nor are applicable 
across all age groups (children, adults, elderly) [9].  
 
Less commonly, instruments may also allow patients to modify their content or scoring 
system to adapt to their own circumstances. These include individualised PROMs, such as the 
Person Generated Index [10]. Computer-adaptive PROMs, in which the most relevant items 
are iterative selected and administered by a learning computer algorithm until sufficient 
information about the patient is collected, also provide an alternative. Individualised and 
computer-adaptive PROMs will be considered in greater depth later in the review. 
 
The number of PROMs has greatly expanded in the recent years, and the two most 
comprehensive databases identify a large number of instruments (PROQOLID (711) [11] and 
BIBLIOPRO (1356) [12]). The co-existence of competing measures aimed at the same 
populations has triggered the development of standardised systems for the evaluation of the 
instruments focussing on psychometric properties (validity, reliability, responsiveness, 
interpretability and cross-cultural adaptation) and ease of use (including administration 
burden) with the aim of supporting head to head comparisons, such as EMPRO [13] and 
COSMIN [14, 15].  
 
PROs have most commonly been utilised for research purposes. They have also been utilised, 
albeit less frequently, for monitoring the health of a stated population, typically through 
periodic surveys [16, 17]. In clinical practice, PROs allow for objective measurement of the 
patient’s subjective view of their health status to complement other clinical measures. 
Numerous benefits for using PROs have been cited, such as the screening, diagnosing, 
monitoring of conditions, along with the promotion of patient centred care [18]. In theory, 
however, there are many more potential clinical applications (Box 1).  
 
[INSERT BOX 1 SOMEWHERE AROUND HERE] 
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Each of these potential applications can be considered plausible because PROs are measures 
of health status. Unlike measures related to processes of care, which are intermediate 
products of the health system, these are endpoints relevant to the patient. Unlike measures 
of patients’ satisfaction with care, they do not focus on an evaluation of the standards of care, 
but rather on the impact that care itself has on the health of individuals. PROs have now, 
however, joined measures of processes of health care, along with patient experience and 
satisfaction, in the armamentarium of feedback and measurement tools for improving the 
quality of health care. There have also been barriers to their use in clinical settings, for 
example, rather than being considered a helpful addition they have often been regarded as 
disruptive to health care. There has also been a perceived lack of expertise on the part of 
clinicians with regards to the interpretation and application of such measures. 
 
Evidence for using PROs in clinical practice 
 
A number of systematic reviews have been conducted aiming to evaluate the impact of using 
PROMs in clinical practice [33, 34, 35, 9, 27] and a wide reaching Cochrane review on the 
routine provision of PROMs to healthcare providers and patients is currently underway 
[36].  Other PROM related systematic reviews have focussed on mental health [37, 
38]; oncology [39] and palliative care [40] (one with a focus on barriers and facilitators for 
implementation, and two scoping reviews have concentrated on aspects of routine feedback, 
including a typology of the diverse ways in which PROMs have been used in mental health 
services [41], the impact on health outcomes, and implementation factors in routine cancer 
care [42]. 
 
Of those systematic reviews which have taken a broad perspective including all type of 
conditions, settings and measures [33, 31, 43, 36] the most cited is Valderas et al (2010) which 
critically appraised the impact of routinely measuring patient-reported outcomes in clinical 
practice across 34 randomised clinical trials. These reviews have found evidence for impact 
upon the processes of care, specifically, an increase in the rate of diagnoses and chart 
notations for the conditions targeted by the interventions. This observation was confirmed 
for the specific use of PROMs for screening and case finding of depression in another 
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systematic review, although this significant although limited effect (Relative Risk (RR) 1.38; 
95% CI 1.04 to 1.83) was mostly due to the effect of a reduced number of studies in which 
patients were considered eligible only when scoring above a certain severity threshold. 
Similarly, there was also a positive effect on the advice and education provided by the 
healthcare professionals. However, no changes were observed in terms of medication and 
similarly, no impact was observed on the management of depression. 
 
The impact of the use of PROMs on outcomes of care remained inconclusive for the vast 
majority of the systematic review except for the specific use of PROMs for feedback on 
treatment outcome in mental health specialist settings: a significant positive short-term 
effect on mental health was observed which did not prevail in the long run (effect size d = 
0.10; 95% CI 0.01–0.19).  
 
Valderas [9] identified a total of 36 endpoints for the randomised controlled trials (RCTs) 
included in the systematic review, which appears to reiterate the lack of consensus amongst 
researchers in relation to how interventions should work and thus what constitutes a relevant 
indicator when using PROMs in clinical practice. In addition, these systematic reviews have 
consistently observed methodological limitations with regards to design and analysis. 
Critically, many interventions did not consider providing training on how to interpret the 
information collected by the PROMs. More importantly, many studies demonstrated an 
incomplete understanding of the mechanisms of by which the intervention operates [9, 18, 
44]. In this way, a considerable methodological limitation is that they have attempted to 
establish the impact of the use PROs on distal primary outcomes, such as improvement on 
health status, without understanding impact upon proximal outcomes, for instance 
communication between patients and the healthcare professionals [45, 46].  
 
The potential effect of the use of PROMs on health outcomes is crucially mediated by the 
modification of the behaviour of both patients and professionals [9, 30]. ‘Patient centredness’ 
is a critical component in this model, and while all PROMs are self-reports of the patient’s 
health status, only some of them explicitly focus the evaluation on those areas that are most 
relevant for each patient. Individualised patient reported outcome measures (iPROMs) are 
concerned with areas which are directly nominated by patients themselves [3], research 
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conducted in the UK has highlighted the need to incorporate individualised assessment 
alongside standard measures [44]. 
 
Lessons learned from using PROs at the aggregate level 
 
The extent to which PROs have been implemented in clinical settings globally has, to date, 
been somewhat varied. PROMs are currently at the centre of an extensive programme for the 
orientation of the NHS in England, the largest and oldest single-payer healthcare system in 
the world, towards a performance model based on health outcomes. This marks the most 
ambitious programme implementing PROMs to date globally, the first time that all patients 
undergoing specific interventions have been invited to complete measures before and after 
specific treatments [Link to website]. Given the scale of the NHS programme a detailed 
examination of implementation in clinical practice in England, and lessons that can be learned 
from this, is particularly relevant. 
 
The NHS PROMs programme has been operating since 2009. Under this mandatory 
programme PROMs (the EQ-5D alongside condition-specific instruments), have been 
collected for all NHS patients undergoing one of four elective surgical procedures (hip 
replacement, knee replacement, varicose vein, and groin hernia surgery), both before and 
after surgery [22]. The PROMs Programme has focused on the collection of the aggregation 
of patient scores for comparison of providers rather than to inform individual patient 
management and clinical decision making. Information is collected at an individual level while 
feedback takes place at a group level, while such feedback has limitations, the resources 
involved in gathering such information in the first place are extensive, and many lessons can 
potentially be learned from this to inform clinical decision making. A substantial body of 
knowledge on the routine collection and feedback of these measurements is developing as a 
result of its evaluation, particularly in terms of rationale, feasibility, and impact [23-31].  
 
[INSERT BOX 2 SOMEWHERE AROUND HERE] 
 
 
Manuscript for J Comparative Effect Res    
9 
Health Services & Policy Research Group, University of Exeter 
Policy makers now possess evidence about many aspects of the use of PROs in order to drive 
quality improvement.  Firstly, a weak association is observed between PROMs and patient 
reported experience measures (PREMs) [23]. Secondly, it is feasible to organise data 
collection and feedback on a national scale, with modest recruitment rates (45%-68% 
depending on the intervention) with a high post-operative response (65%-85%) [24, 25]. 
Thirdly, the choice of metric derived from PROMs makes a substantial difference to the 
results, such as the proportion of providers defined as ‘poor’ [24]. 
 
Although the PROMs programme has been positive in the sense that many participating 
patients reported valuing their experience, there was, however, no discernible impact on 
patient outcomes over its first three years [26]. This may be because providers only started 
receiving feedback in the third year of the programme, in addition the presentation of 
feedback was, at the time, not of high quality, and there was little room for improvement for 
the selected procedures. However, the evidence for using feedback on PROMs for quality 
improvement at a group level is severely limited. A systematic review [27] was only able to 
identify one study with methodological limitations that, not surprisingly, did not observe a 
positive impact [28].  
 
The underlying assumption is that measurement of PROs, along with clear feedback and 
dissemination of this information, will stimulate and incentivise health professionals and 
ultimately health trusts to provide better care [30].  A key challenge is how to bridge the gap 
between the information that is provided at the aggregate level with changes in care delivery 
based on individual patients [1, 31]. So far, these two agendas have developed relatively 
independently of each other, without joined-up thinking about how they might come 
together. For example, it will be essential to maintain high response rates for aggregate use 
of PROMs to monitor quality; this is much more likely if there is engagement by health 
professionals and patients. More importantly it is difficult to anticipate how clinicians will be 
able to identify opportunities for improvement of care as measured against the standard of 
PROM scores unless these scores are part of their daily experience of managing patients. The 
expansion of the clinical applications of PROMs will be pivotal to the success of the whole 
PROMs programme. A realist synthesis of the literature is underway [32] to help identify 
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users’ aims and the theories underlying their expectations and will put these observations in 
an appropriate context.  
 
 
A framework for implementing PROs in clinical practice  
 
Using available evidence from systematic reviews and from qualitative research with patients 
and health professionals [43, 47, 48], along with specific guidelines for implementing outcome 
measures in clinical practice [49-51], and the evidence from available experiences, we have 
developed a framework of key requirements for the successful implementation of PROs in 
clinical practice (Box 2). 
 
[INSERT BOX 3 SOMEWHERE AROUND HERE] 
 
Based on this, six key issues have been identified that need to be considered when 
implementing PROs in clinical practice: the characteristics of the PRO itself, the purpose of 
using the measure, the feedback system, the setting,  specific additional support to the 
implementation, as well as targeting patients and health professionals that are most likely to 
benefit from it. Specific requirements include training for clinicians on the administration and 
interpretation of PROMs; the use of existing information systems for feedback to clinicians, 
that is frequent and timely; and the provision of information that is linked to specific actions, 
among others [9, 18, 52].  
 
We present a practical example of how these requirements can be operationalised, based on 
a study evaluating the use of PROs for children with advanced cancer in the USA (Box 4). This 
randomised controlled trial, conducted at three large paediatric cancer centres, 
comprehensively considers the issues of implementing PROMs in clinical practice with lessons 
that can be applied elsewhere. In this study, the use of PROs was used to support the routine 
monitoring of children and teens undergoing treatment, and allowed clinicians to 
systematically track symptoms and health related quality of life over time. The design of the 
study incorporated the key issues we have identified above (and in Box 2), in particular special 
consideration was given to feedback for both families and providers, with printed reports and 
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emails provided immediately after survey completion. Families and providers were also 
offered training in how to interpret the results. The study authors also acknowledged 
potential limitations to their feedback intervention, in that it may have lacked leverage 
required to affect clinical behaviour and subsequent referrals. The limitation of feedback 
linked to treatment decision making is observed in comparable studies [ref] and constitutes 
and ongoing barrier to the take up of PROs in clinical practice. 
 
[INSERT BOX 4 SOMEWHERE AROUND HERE] 
 
Our framework for the implementation of PROs in clinical practice also provides insight into 
the ultimately unsuccessful implementation of PROs for the assessment of depression as part 
of the Quality and Outcomes Framework (QOF), an incentive scheme for Primary care services 
covering the vast majority of the population of England (Box 5). In particular, neither training 
nor specific indications were given on which measure to choose and the rationale for a choice, 
when or how to introduce the measure, when to collect the score, or how to introduce it 
within the flow of a clinical appointment, and scarce information was provided regarding the 
instruments themselves [54]. The feedback system was also considered poor, with the scores 
not being available in a timely fashion, lack of time for integrating the information provided 
by PROs with other clinical information, and irregular feedback. The only elements that were 
considered were to select instruments tailored to the setting and to link PRO scores 
(depression severity) to specific action (treatment options), through explicit reference to the 
National Institute for Health and Care Excellence (NICE) guideline for the management of the 
condition [55] (NICE is a public body providing national guidance and advice to improve health 
and social care in England). As such, the framework, as outlined, provides a means of learning 
from the lessons of the past, indicating ways PROs can be more successfully implemented in 
clinical practice in the future. 
 
[INSERT BOX 5 SOMEWHERE AROUND HERE] 
 
Future developments  
 
The potential of individualised PROs 
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A key challenge facing health care systems across the world concerns how to promote patient 
centred care in the context of the increasing demands of patients managing multiple, long-
term conditions. It is estimated that between a quarter and half of primary care patients have 
more than one health problem [61, 62]. Even though clinically complex patients have an 
increased use of healthcare services than other members of the population, they face worse 
health outcomes [63, 64]. The use of iPROMs, where the patient can explicitly prioritise which 
conditions or symptoms to address, offers the potential of aligning the priorities of patients 
and professionals.  
 
iPROMs are measures for which individual respondents are actively involved in the 
specification of content and/or scoring of each item [65]. Such measures empower patients 
to evaluate the relevance of different aspects of their health conditions [66], either by 
selecting the specific domains, weighing their importance, or both [67, 3]. By tailoring the 
questionnaire to the person’s own perspective, iPROMs have a higher likelihood of detecting 
issues that may be relevant in clinical practice, as well as being responsive to the individual 
aspects of health related quality of life [68]. iPROMs are more likely to be able to detect a 
change in patient’s health status than standardised tools alone (in turn, among standardised 
tools condition specific instruments will tend to prove more responsive than more generic 
ones). They may be particularly useful for patients with multiple conditions in helping them 
to convey to practitioners which aspects of their health they would like to be prioritised. 
 
Despite their ability to convey personal preferences and idiosyncratic aspects from the 
patient’s perspective, there are some disadvantages of using iPROMs, both from a structural 
and a methodological perspective. Structural disadvantages include the burden associated 
with administration, at the researcher, clinical and patient level [67]. Methodological issues 
include the absence of a common metric, which raises concerns regarding analyses and 
comparison of results (not only between patients but also for the same patient across time), 
and the possibility of successively obtaining floor effects if the items generated by the patient 
are too idiosyncratic [68]. Moreover, distinct processes are used for item and content 
generation, resulting in wide-ranging levels of individualisation [68]. This results in measures 
with different degrees of individualisation, ranging from those individualised at the content 
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level, where the respondent can nominate the items (e.g., the Goal Attainment Scaling) to 
those where the items are provided to the respondent, who is then able to rate the 
importance and relevance of each item, thus being individualised at the scoring level (e.g., 
the Audit of Diabetes Dependent Quality of Life [69]. Given these issues it is vital to ensure 
that iPROMs are methodologically rigorous and fit for purpose. Currently none of the major 
systems for the standardised evaluation of PROs considers degrees and quality of 
individualisation [9, 15, 70]. There is, therefore, a pressing need to establish, through expert 
consensus, rigorous evaluation standards for assessing the methodological quality of iPROMs, 
along with an acceptable definition of such measures. 
 
The administration of different combinations of standardised and individualised PROMs could 
provide an alternative to the current, compartmentalised remit of health provision, allowing 
for multiple conditions to be addressed within a single health care consultation and help to 
drive forwards patient centred prioritisation. But the question still remains about whether 
the same PRO can be used for both purposes. 
 
Item Banks and computer adaptive tests 
 
As we move further into the information age, the greater availability of ‘smart’ computing 
solutions alongside increasing application of advanced psychometric models to health care 
PROMs grants a number of new and exciting opportunities to enhance PRO use in clinical 
practice.  
 
In the field of psychometrics, ‘modern’ measurement theories are increasingly being utilised 
to create questionnaires that are both shorter and more accurate than those developed using 
‘classical’ methodologies [58, 71]. These include item response theories [72] and the Rasch 
model [73], are being increasingly adopted in health services research and have recently been 
used to develop PROs which measure wide-ranging phenomena including pain, depression, 
fatigue, and the impact of multimorbidity [74-77].  However, in other fields where 
questionnaires are used to capture ‘high stakes’ information, such as educational testing and 
psychometric assessment for employers, they have been considered the industry standard 
for decades [78].  
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One key attribute of item response theory is the ability to calibrate precise item parameters 
(the degree of the underlying phenomena they measure), rather than simply applying an 
ordinal integer value to a response. In practice, this means that the validated scales may be 
administered using any number or combination of items; rather than it always being 
necessary to administer the entire scale to each respondent. This had led to the increasing 
development of large ‘banks’ of psychometrically calibrated questionnaire items, known as 
item banks [79].  
 
One of advantage of item banks is their ability to capitalise on ‘intelligent’ computerised 
questionnaire administration algorithms, especially computer adaptive tests (CATs); which 
can improve the quality of measurement whilst administering fewer items than a standard 
paper-based questionnaire [80]. Computer adaptive testing improves measurement by 
selecting the most appropriate items for each patient, based on their previous responses. For 
example, when administering a functional impairment questionnaire using CATs, the 
computer would be unlikely to administer an item that represents a very high level of 
functional impairment (e.g. “I have problems getting dressed”) once it had decided (following 
pervious item responses) that the respondent probably had very little impairment (for 
example, if they responded positively to a statement about exhausting exercise). 
Questionnaires using CAT usually take a fraction of the time to complete and, because of the 
rigorous item bank development, can be even more reliable, valid and sensitive to change 
than compared to their paper-based counterparts [81]. Despite the complexity of the 
underlying CAT algorithms, their administration is straightforward and has been shown to be 
acceptable and accurate across diverse populations, including older adults [82] and children 
[83]. 
 
Taken at face value, the increased precision and brevity of CATs may appear to be their most 
appealing feature in busy clinical environments. But there are other significant benefits to 
using this technique in clinical practice. The ability of CATs to accurately ‘target’ questionnaire 
items means that patients may be spared from responding to items which are either plainly 
obvious or potentially distressing; such as an item asking a patient in the very early stages of 
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a progressive degenerative disease if they are experiencing the high levels of impairment that 
are typical of later disease stages.  
 
The computerised nature of CAT grants a number of other significant benefits for PRO 
administration. These include the immediate provision of feedback, which can be 
automatically tailored to the individual responses of the patient. More practical advantages 
provided by computerised administration include no missing data and automatic scoring, 
inputting and storing. These issues have all been shown to be important barriers to the uptake 
of PROs in clinical practice [84].  
 
Future perspectives 
 
The coming years have exciting potential for the use of PROs in clinical practice, and we 
predict a number of ways in which the field will evolve over the next decade. As technology 
plays an ever greater part in society and healthcare systems, we anticipate that computerised 
devices incorporating CAT, such as tablets, will be used for the increased collection and 
feedback of PROs, making effective use of both standardised and individualised measures, 
incorporating personalised feedback for both clinicians and patients. We also anticipate such 
application will be implemented in an increasingly longitudinal fashion, for PRO scores to 
become part of clinical reviews over time, linked to changes in patient outcomes, activation 
and goal setting. As part of this it will be important that clinical staff are trained in the 
understanding and application of PROMs, to avoid mistakes of the past, which will involve 
developing expertise in how to interpret measures and feed this information back to patients 
in order to inform treatment. At present there is a lack of link up with PROs and clinical 
decision making, as to how interpretation of measures can directly influence clinical decision 
making at the “bed-side”. This constitutes and area that needs to be addressed in coming 
years, a more comprehensive framework needs to be developed in order to provide greater 
guidance to clinicians as to how confident they can be in measured values, and how 
interpretation of such values can be linked to a range of appropriate treatment options.  
 
Conclusion/Discussion  
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PROs have a role to play in clinical practice and the evidence of this is becoming stronger. 
However, there is currently more compelling evidence for impact upon the processes of care, 
than on outcomes of care. A key barrier for implementation continues to be lack of alignment 
with current clinical processes, particularly in terms of insufficient linkage between 
interpretation of scores and clinical decision making on the ground. 
Based on available evidence we have developed a framework of the key requirements for the 
successful implementation of PROs in clinical practice, encompassing the instrument itself, 
purpose of the PRO, the feedback system, setting, specific additional support to 
implementation, as well as characteristics of patients and health professionals involved (along 
with training for clinicians on the administration and interpretation of PROs). In the future 
this framework could be further developed into a “bed-side” tool kit providing clinicians with 
confidence in values, how to interpret them, and link them to treatment options (in a way 
that is responsive to the needs of the patient). 
We are now starting to see effective of administration and instant feedback of PROs through 
computerised devices. The next logical step in this is to develop enhanced relevance to the 
each patient. Most previous efforts have focussed on the use of fully standardised measures 
thereby limiting opportunities to tailor measurement to individual preferences. To this end 
individualised measurement and efficient administration through the use of CAT represent 
very promising developments for further uptake of PROs in clinical practice, administering 
measures in a way that is appropriate and responsive to each patient and different aspects of 
their health conditions. Crucially CATs offer a stream lined approach which can reduce burden 
compared to the time required to complete PROMs through traditional means, this in itself 
offers a key advantage to stretched health care systems going forwards. 
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Box 1. Potential clinical applications of PROs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 2. Potential applications of feedback on PROs for quality improvement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Within a single service: 
– Evaluation of performance of the service as a whole along the time and for audit 
– Comparing outcomes between different user groups 
– Contributing to the evaluation of individual clinicians’ practice and/or for comparing 
performance across clinicians in the same service   
• Across multiple services:  
– Evaluation of performance of the system as a whole along the time  
– Comparing performance of individual services 
– Comparing outcomes between different user groups 
 
 Within a single service: 
-Evaluation of performance of the service as a whole along the time and for audit 
-Comparing outcomes between diff rent user groups 
-Contributing to the evaluation of individual clinicians’ practice and/or for comparing performance 
across clinicians n the sam  service   
 Across multiple services:  
-Evaluation of performance f the sy tem as a whole along the time  
-Comparing performance of individual services 
-Comparing outcomes between different user groups 
 
• Supporting decision making in the diagnostic process: 
– Screening 
– Diagnosis 
• Informing risk stratification and prognosis (identification of vulnerable 
patients and patients “at risk”) 
• Supporting prioritisation and goal setting 
• Supporting decision making in indication for treatment (medical/surgical) 
• Facilitating monitoring of 
– General health status  
– Response to treatment/management 
• Facilitating communication 
– Between patients and health professionals 
– Within teams and between professionals: consistent use along the 
care pathway 
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Box 3. Framework of key issues and requirements for the successful implementation of 
PROs in clinical practice 
 Clinical activity:  
o Screening 
o Diagnosis 
o Risk stratification and prognosis  
o Prioritisation and goal setting 
o Indication for treatment (medical/surgical) 
o Monitoring of 
 General health status  
 Response to treatment/management 
o Facilitating communication 
 Between patients and health professionals 
 Within teams and between professionals (along care pathways) 
 PROM instrument:  
o Simple (low burden of administration) 
o Valid (in particular, face validity)  
o Responsive 
o Interpretable: explicit link between PROMs outputs and clinical activity 
o Tailored to the particular setting and purpose  
 Feedback system: 
o Integrated in clinical information systems 
o Structured, with explicit interpretation of the individual scores 
o Targeting both all relevant health care professionals and patients  
o Frequent and timely  
o Supported by training of patients and health professionals on the 
interpretation of scores and outputs 
 Setting: 
o Questionnaire friendly environment 
 Support to the implementation: 
o Training 
o Additional resources 
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 In addition, the effectiveness of the implementation can be maximised by targeting 
specific groups most likely to benefit from this approach of  
o Patients: male, previously unknown to the clinician, with perceived 
borderline status of measurement in relation to the clinical activity 
o Health professionals: low familiarity/degree of confidence in the clinical 
activity  
 
 
Box 4. Use of feedback of PROs aiming to improve the Care of Children with Advanced 
Cancer 
This is the first RCT designed to test a PRO feedback intervention among children and teens 
with advanced cancer. Wolfe and colleagues [x] assessed 339 children for eligibility, with 
104 allocated to either the intervention arm of the study or the control group. The control 
group completed questionnaires using tablet computers no more than once a week: 
Paediatric Quality of Life and Evaluation of Symptoms Technology (PQ) survey consisting of 
age and respondent-adapted versions of the Memorial Symptom Assessment Scale (MSAS), 
Paediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL4.0), and an overall 
Sickness question. Oncologists and families received printed reports summarising PROs; e-
mails were sent to oncologists and subspecialists when predetermined scores were 
exceeded. The control group completed the questionnaires but no feedback was provided. 
The feedback intervention had two components: PQ reports and PQ e-mails. PQ reports 
were printed reports that were given to providers before the visit and to families 
immediately after survey completion. PQ reports (Data Supplement) consisted of bar plots 
of PedsQL4.0 and MSAS symptom scores from current and four prior administrations, a 
summary highlighting changes since the last report, and a list of available resources for 
symptom control (for families) or generic pain management recommendations (for 
providers). Training on how to interpret PQ reports was offered to families at enrolment 
and annually to providers. Primary outcomes included linear trends of MSAS, PedsQL4.0 
total and subscale scores, and Sickness scores during 20 weeks of follow-up, along with 
child, parent, and provider satisfaction with PQ feedback. Although routine feedback of 
PROs did not significantly affect the child’s symptoms or health-related quality of life 
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(HRQL), changes were in expected directions and improvements observed in emotional 
HRQL through exploratory analyses were encouraging. Importantly, children, parents, and 
providers valued PRO feedback. Post hoc subgroup analyses found larger and statistically 
significant improvements on the HRQL emotional domain scores and the sickness question 
for patients who survived longer than 20 weeks. 
 
 
 
Box 5. PROs in the Quality and Outcomes Framework (QOF) 
In addition to PROMs being implemented as part of the NHS PROMs programme, PROMs 
have also been implemented in Primary Care as part of the Quality and Outcomes 
Framework (QOF), a voluntary annual reward and incentive scheme in Primary Care. The 
programme was, once again, considered unsuccessful. Incentives for the assessment of the 
severity of depression at diagnosis and at follow up using a standardised PROMs were 
introduced in the QOF in 2006 [54]. Minor changes were introduced in the course of the 
subsequent years. Other than being directed to three specific scales validated for using in 
primary care (Patient Health Questionnaire [PHQ], Beck Depression Inventory Second 
Edition [BDI-II], and Hospital and Anxiety Depression Scale [HADS]), [55], GPs received no 
specific guidance regarding the implementation of the data collection and feedback system.  
 
The indicators were quickly adopted by the practices, as evidenced by data provided by the 
Health and Social Care Information Centre (Appendix).  In 2006/2007 two out of three 
practices achieved the maximum amount of points, a proportion that increased to four out 
of five by 2011/2012. Although these figure may indicate a degree of success, qualitative 
research with patients and health professionals suggested that the use of PROs was not 
having the desired impact on either group. 
 
Patients overall favoured the use of PROs, which they considered a useful supplement to 
clinical judgement that could aid the GP in the diagnosis, management, and monitoring of 
depression [47, 56]. They also noted their usefulness in providing feedback and raising 
awareness of symptoms of depression [47, 56]. Of particular interest, patients perceived 
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the administration of these instruments as confirmation of their problems and as evidence 
that their GP was taking their problems seriously [47]. 
 
The perceptions of clinicians, however, were substantially different. Multiple concerns 
were raised in relation to the applicability, administration, and interpretation of the 
PROMs. Lack of specific training [57] and simply not knowing when and how to administer 
the measures were major problems. Faced with a lack of guidance on the questionnaires 
might be used in clinical practice and the challenge of fitting their administration into a ten 
minute consultation GPs often introduced significant changes to established administration 
procedures, affecting where and how the measure was completed, and the number of 
questions asked [57] and compromising the validity of the scores [58]. It was also not always 
clear to GPs how to interpret the scores [48]. The PROMs were often not considered as an 
integral part of assessment and diagnosis, and their administration was felt to disrupt the 
normal flow of the consultation, [48, 57], while adding an additional burden to the workload 
and roles of GPs and practice nurses [59]. Perhaps not surprisingly GPs concerns on the use 
of these PROMs have resulted in their use no longer being specifically incentivised as part 
of QOF [60].  
 
 
 
 
 
 
 
